Funded Tech Companies

ImpriMed

ImpriMed, based in Palo Alto, received equity investments through SK Telecom Ventures, Murex Partners and Ignite Innovation Fund.

Company Overview

Contact Information

Company Background Information

Overview

ImpriMed develops a personalized drug testing service to look into drug responses of pet patient's live cancer cells before treatment. The company helps veterinary oncologists decide a final treatment regimen based on data-driven prediction of response success in each individual patient body and builds up a patient-derived database.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/19/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sungwon Lim

        

Co-Founder

Mainak Chowdhury

        

Co-Founder

Jamin Koo

        

Co-Founder

David Kurtz

        

Co-Founder

Hye Lee

        

VP - Operations

Mary Ocnean

        

Company Investors

• SK Telecom Ventures
• Murex Partners
• Ignite Innovation Fund
• Samyang Chemical Group
• SoftBank Ventures Korea
• Han River Partners
• KDB Industrial Bank
• Byucksan
• HG Initiative
• FuturePlay
• Murex Investments
• Draper Associates
• Translink Capital
• ES Investor
• DraperDragon
• Primer Sazze Partners
• BonAngels Venture Partners
• StartX
• Plug and Play Ventures

Browse more funded tech companies:

Impress Software | Imprint

Share this article

About Our VC & M&A Database

The company data above is provided by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary